Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Droz

Showing results (241-250 of 364) with videos related to

Pageof 37
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumoursJ Kattan, M Mahjoubi, J P Droz, et al.
Annales De Gastroenterologie Et D'Hepatologie|February 1, 1985
[Treatment of hepatic metastases with unknown primary cancer]G Piot, J P Droz, P Rougier, et al.
Bulletin Du Cancer|January 1, 1990
[Chemotherapeutic intensification in germ cell tumors]J P Droz, J L Pico, M Ghosn, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1985
[Locoregional chemotherapy of hepatic metastases]P Rougier, G Piot, P Lasser, et al.
British Journal of Cancer|October 6, 2005
The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface areaA-C Piketty, A Fléchon, A Laplanche, et al.
Gynecologic Oncology|July 1, 1992
Ovarian dysgerminoma metastatic to the breastJ Kattan, J P Droz, P Charpentier, et al.
Bulletin Du Cancer|October 1, 1976
[Embryonic antigen in head and neck tumors]J L Amiel, R Henry, van den Broucke, et al.
The Prostate|January 1, 1994
Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostateJ P Droz, E De Smedt, J Kattan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapyK Fizazi, S Culine, J P Droz, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1988
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinomaZ Pastran, T le Chevalier, P Baldeyrou, et al.
Pageof 37

Showing results (241-250 of 364) with videos related to

Sort By:
Pageof 37
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumoursJ Kattan, M Mahjoubi, J P Droz, et al.
Annales De Gastroenterologie Et D'Hepatologie|February 1, 1985
[Treatment of hepatic metastases with unknown primary cancer]G Piot, J P Droz, P Rougier, et al.
Bulletin Du Cancer|January 1, 1990
[Chemotherapeutic intensification in germ cell tumors]J P Droz, J L Pico, M Ghosn, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|January 1, 1985
[Locoregional chemotherapy of hepatic metastases]P Rougier, G Piot, P Lasser, et al.
British Journal of Cancer|October 6, 2005
The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface areaA-C Piketty, A Fléchon, A Laplanche, et al.
Gynecologic Oncology|July 1, 1992
Ovarian dysgerminoma metastatic to the breastJ Kattan, J P Droz, P Charpentier, et al.
Bulletin Du Cancer|October 1, 1976
[Embryonic antigen in head and neck tumors]J L Amiel, R Henry, van den Broucke, et al.
The Prostate|January 1, 1994
Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostateJ P Droz, E De Smedt, J Kattan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapyK Fizazi, S Culine, J P Droz, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1988
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinomaZ Pastran, T le Chevalier, P Baldeyrou, et al.
Pageof 37